MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics Shares 2011-2025 | SLNO
Annual Shares Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.2 M | 16.5 M | 8.4 M | 5.32 M | 79.6 M | 34.1 M | 21 M | 8.98 M | 3.1 M | 1.89 M | 254 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.6 M | 254 K | 19.9 M |
Quarterly Shares Soleno Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 M | 50.5 M | 46.2 M | 45.7 M | 41.9 M | 38.6 M | 36.2 M | 31.7 M | 11.4 M | 10.4 M | 9.45 M | 8.16 M | 8.09 M | 9.34 M | 5.33 M | 5.32 M | 5.32 M | 79.7 M | 79.7 M | 79.6 M | 79.6 M | 46.2 M | 44.7 M | 44.7 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 21.4 M | 20.3 M | 19.5 M | 19.2 M | 9.67 M | 9.52 M | 5.09 M | 3.36 M | 3.15 M | 15.5 M | 14.8 B | 14 M | 10 M | 7.52 M | 6.97 M | 6.77 M | 536 K | 536 K | 536 K | 536 K | 536 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.8 B | 536 K | 326 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M |  USA |
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 38.85 | 2.32 % | $ 1.08 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.36 | -4.05 % | $ 176 M |  China |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 17.05 | -2.15 % | $ 99.4 M |  Israel |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
731 M | $ 227.08 | -2.28 % | $ 166 B | USA |
 |
Exact Sciences Corporation
EXAS
|
185 M | $ 101.58 | 0.21 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 27.13 | 0.26 % | $ 820 M | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.63 | -2.11 % | $ 2.07 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
386 M | $ 66.91 | -2.94 % | $ 25.8 B | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 11.92 | -6.58 % | $ 338 M | Israel |
 |
Illumina
ILMN
|
159 M | $ 134.29 | -1.58 % | $ 21.4 B | USA |
 |
IQVIA Holdings
IQV
|
181 M | $ 221.54 | -1.96 % | $ 40.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Lantheus Holdings
LNTH
|
69.2 M | $ 66.11 | 4.76 % | $ 4.57 B | USA |
 |
Guardant Health
GH
|
123 M | $ 102.09 | 0.7 % | $ 12.5 B | USA |
 |
CareDx, Inc
CDNA
|
53.8 M | $ 20.44 | 3.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 105.26 | 4.46 % | $ 4.15 B | USA |
 |
Anixa Biosciences
ANIX
|
31.9 K | $ 3.59 | -25.21 % | $ 115 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.34 | -2.96 % | $ 9.98 M | USA |
 |
Myriad Genetics
MYGN
|
90.6 M | $ 7.26 | -0.62 % | $ 658 M | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 6.86 | -2.63 % | $ 1.49 B | USA |
 |
National Research Corporation
NRC
|
24.5 M | $ 17.81 | 2.24 % | $ 437 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 263.51 | -0.46 % | $ 22.1 B | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
254 M | $ 2.13 | -1.61 % | $ 540 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 26.6 | -1.52 % | $ 20 B |  Niderland |
 |
Psychemedics Corporation
PMD
|
5.74 M | - | -1.84 % | $ 15.3 M | USA |
 |
Charles River Laboratories International
CRL
|
51.4 M | $ 192.57 | -0.96 % | $ 9.89 B | USA |
 |
Quidel Corporation
QDEL
|
42.1 M | $ 28.79 | -2.93 % | $ 1.21 B | USA |
 |
Quotient Limited
QTNT
|
91.6 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
RadNet
RDNT
|
73 M | $ 75.0 | -4.65 % | $ 5.48 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 182.21 | 0.35 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
130 M | $ 7.94 | -1.0 % | $ 1.03 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 186.28 | -1.92 % | $ 15.4 B |  Irlanda |